196 related articles for article (PubMed ID: 34454530)
21. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker.
Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
J Clin Pathol; 2014 Jun; 67(6):520-8. PubMed ID: 24607493
[TBL] [Abstract][Full Text] [Related]
23. Insulinoma-associated Protein 1 Expression and Its Diagnostic Significance in Female Genital Tract Neuroendocrine Carcinomas.
Ting CH; Wang TY; Wu PS
Int J Gynecol Pathol; 2021 Sep; 40(5):452-459. PubMed ID: 33323849
[TBL] [Abstract][Full Text] [Related]
24. Prognostic implications of synaptophysin, CD56, thyroid transcription factor-1, and Ki-67 in pulmonary high-grade neuroendocrine carcinomas.
He Y; Zhao L; Tang X; Jiang Q; Zhao X; Cao Y
Ann Diagn Pathol; 2024 Feb; 68():152239. PubMed ID: 38006863
[TBL] [Abstract][Full Text] [Related]
25. Distribution of Neuroendocrine Marker-Positive Cells in Colorectal Cancer Tissue and Normal Mucosal Tissue: Consideration of Histogenesis of Neuroendocrine Cancer.
Ogimi T; Sadahiro S; Kamei Y; Chan LF; Miyakita H; Saito G; Okada K; Suzuki T; Kajiwara H
Oncology; 2019; 97(5):294-300. PubMed ID: 31390635
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine Differentiation in Thymic Carcinomas: A Diagnostic Pitfall: An Immunohistochemical Analysis of 27 Cases.
Weissferdt A; Moran CA
Am J Clin Pathol; 2016 Mar; 145(3):393-400. PubMed ID: 27124922
[TBL] [Abstract][Full Text] [Related]
27. The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas.
Lai BS; Tsang JY; Poon IK; Shao Y; Chan SK; Tam FK; Cheung SY; Shea KH; Tse GM
Oncologist; 2020 Sep; 25(9):e1318-e1329. PubMed ID: 32472950
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.
Ekmekcioglu S; Davies MA; Tanese K; Roszik J; Shin-Sim M; Bassett RL; Milton DR; Woodman SE; Prieto VG; Gershenwald JE; Morton DL; Hoon DS; Grimm EA
Clin Cancer Res; 2016 Jun; 22(12):3016-24. PubMed ID: 26783288
[TBL] [Abstract][Full Text] [Related]
29. Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma.
Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
J Eur Acad Dermatol Venereol; 2015 May; 29(5):912-8. PubMed ID: 25199412
[TBL] [Abstract][Full Text] [Related]
30. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
Sakakibara R; Kobayashi M; Takahashi N; Inamura K; Ninomiya H; Wakejima R; Kitazono S; Yanagitani N; Horiike A; Ichinose J; Matsuura Y; Nakao M; Mun M; Nishio M; Okumura S; Motoi N; Ito T; Miyazaki Y; Inase N; Ishikawa Y
Am J Surg Pathol; 2020 Jun; 44(6):757-764. PubMed ID: 32118626
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical study of 49 cutaneous melanomas: p53, PCNA, Bcl-2 expression and multidrug resistance.
Loggini B; Rinaldi I; Pingitore R; Cristofani R; Castagna M; Barachini P
Tumori; 2001; 87(3):179-86. PubMed ID: 11504374
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
[No Abstract] [Full Text] [Related]
33. A simple and practical index predicting the prognoses of the patients with well-differentiated pancreatic neuroendocrine neoplasms.
Liu B; Kudo A; Kinowaki Y; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Tanaka S; Akashi T; Tanabe M
J Gastroenterol; 2019 Sep; 54(9):819-828. PubMed ID: 30863885
[TBL] [Abstract][Full Text] [Related]
34. Expression and Clinicopathological Significance of SOX11 in Small-Cell Lung Cancer.
Xinli W; Lixiao W; Baoqi D; Hu H; Qiang Z
Biomed Res Int; 2022; 2022():1707914. PubMed ID: 35402616
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Yao W; Wang W; Li G
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
[TBL] [Abstract][Full Text] [Related]
37. Small and Isolated Immunohistochemistry-positive Cells in Melanoma Sentinel Lymph Nodes Are Associated With Disease-specific and Recurrence-free Survival Comparable to that of Sentinel Lymph Nodes Negative for Melanoma.
LeBlanc RE; Barton DT; Li Z; Angeles CV; Ernstoff MS; Bagley E; Wimmer D; Wong SL; Barth RJ; Shirai K; Yan S
Am J Surg Pathol; 2019 Jun; 43(6):755-765. PubMed ID: 31091203
[TBL] [Abstract][Full Text] [Related]
38. High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event.
Knösel T; Chen Y; Altendorf-Hofmann A; Danielczok C; Freesmeyer M; Settmacher U; Wurst C; Schulz S; Yang LL; Petersen I
J Cancer Res Clin Oncol; 2012 Mar; 138(3):397-403. PubMed ID: 22160160
[TBL] [Abstract][Full Text] [Related]
39. Expression of NCAM (CD56), chromogranin A, synaptophysin, c-KIT (CD117) and PDGFRA in normal non-neoplastic skin and basal cell carcinoma: an immunohistochemical study of 66 consecutive cases.
Terada T
Med Oncol; 2013 Mar; 30(1):444. PubMed ID: 23292839
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.
Dai DL; Martinka M; Li G
J Clin Oncol; 2005 Mar; 23(7):1473-82. PubMed ID: 15735123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
